iQemo. Cloud-based chemotherapy prescribing & patient care

Safer, simpler and more efficient

Manage the chemotherapy treatment cycle more safely, more efficiently, and from almost any internet-connected device. iQemo delivers the end-to-end electronic administration and recording of SACT for any organisation providing cancer treatment.

Medical professional works on a computer, with the iQemo logo inset
Photo of smiling patient

People-centric technology that improves patient outcomes, everywhere

Through innovative design, development and services, iQ HealthTech provides tools and solutions to NHS, private and international hospitals and healthcare organisations, with a focus on refining the management of chemotherapy.

With deep expertise in clinical development and years of experience supporting cancer treatment professionals, we're proud to be leaders in our field.

About us

Safer, simpler and more efficient healthcare tools

Resources

Managing Drug Shortages in iQemo

Drug shortages have become a more common occurrence across the healthcare sector, negatively impacting the care delivered to patients and increasing stress amongst healthcare professionals. Shortages are influenced by many factors, from global events (e.g. COVID-19, Russia-Ukraine war) to financial and economical, increasing the cost of the drug and limiting the manufacture (e.g. cost of raw materials and energy to produce the drugs) (1). As a result, drug supply issues are often sudden and require immediate alternatives to be made available. This article aims to provide users with some helpful suggestions for how to manage a drug shortage within iQemo. (1) The Pharmaceutical Journal, PJ, June 2023, Vol 310, No 7974; 310(7974): :DOI:10.1211/ PJ.2023.1.189330

Read more
Resources

Biosimilar switching with iQemo

Biosimilar switching is becoming more common as Rituximab, Trastuzumab and Bevacizumab all have biosimilars on the market. Due to stock shortages and contract prices, there may be a need to switch biosimilars more regularly. This will become more common as additional biosimilar products come to the market. iQemo can facilitate biosimilar switching through several mechanisms.

Read more
Resources

Eight ways iQemo helps improve patient safety

Beyond the standard benefits of e-prescribing, iQemo provides many additional features that will help your organisation further improve the safety of its patients receiving chemotherapy.

Read more
What people say about iQemo

I am just amazed how easy this system is to use when compared to the other e-prescribing systems I use

Dr Andreas Makris
Consultant Clinical Oncologist
Medical professional works on a tablet device and a laptop computer

Modular and configurable

iQemo's modular design makes it highly configurable, with integrations into your existing systems, medical devices (such as smart infusion pumps), and direct ordering from third-party drug manufacturers. iQemo workflows are extremely adaptable, allowing it to complement your existing hospital processes.

iQemo is continually evolving, driven by innovation fed by our committed user base.

Learn more

Latest news and articles

Lyell McEwin Hospital - Northern Adelaide Local Health Network (NALHN), South Australia successfully implement iQemo – September 2023

We are very pleased to report the next successful iQemo activation within SA Health at Lyell McEwin Hospital, Adelaide, South Australia

Read more
News

iQemo is live at Mount Gambier and Districts Health Service, South Australia – July 2023

iQHealthTech in collaboration with Altera Digital Health in Australia have celebrated the successful go-live of iQemo at Mount Gambier and Districts Health Service!

Read more
Customer success

Investing in support (and putting an end to ticket-tennis)

iQ HealthTech upgrade their service desk for improved, email, phone, and technical support.

Read more

We’re working on an innovative future for healthcare technology

Sign up to our newsletter and stay updated with industry-leading advice, insight and more…

Thank you! Your submission has been received!
Sorry, something went wrong while submitting the form.